Six temperature-sensitive mutants of vesicular stomatitis virus (VSV) were isolated from the central nervous system (CNS) of athymic nude mice. The nude mice had been reconstituted with syngeneic T lymphocytes and then infected with a temperature-sensitive mutant of VSV, tsG31-KS5 VSV, for 20 days. In BHK-21 cells incubated at 38 *C, the normal body temperature of mice, all six CNS virus clones had diminished RNA synthesis, when compared to RNA production in BHK-21 cells incubated at 31 °C. In contrast, the original tsG31-KS5 VSV mutant synthesized more RNA at 38 °C than it did at 31 °C. In vitro transcription assays were exploited to discern which viral protein(s) was functionally accountable for the abated synthesis of RNA of the CNS VSV isolates. The ribonucleoprotein complexes from the CNS VSV isolates were disrupted and template (N protein and RNA) and enzyme (L and NS proteins) fractions were purified. In vitro transcription assays were performed with template fractions of the brain isolates, added to enzyme fractions either wild-type wt VSV or tsG31-KS5 VSV, or with template fractions of wt VSV or tsG31-KS5 VSV mixed with enzyme fractions of the CNS isolates. The template fraction was responsible for the decrease in RNA synthesis in all six of the brain-isolated clones. When the template fractions of wt or tsG31-KS5 VSV were mixed with enzyme fractions of all the CNSderived VSV, except BP5A VSV, leader sequence RNA and large Mr transcripts were transcribed. One clone, BP5A VSV, did not synthesize RNA when mixed with either template or enzyme of wt VSV, and probably had more than one functional mutation that influenced viral RNA synthesis.
Introduction
The mechanisms used by viruses to establish persistent infections are largely unknown, although persisting viruses frequently are mutated forms of common viruses (Haywood, 1986) . Certain types of mutations may be critical for the establishment of enduring host-parasite relationships, and temperature-sensitive viruses have been isolated from humans and animals that suffer from chronic virus diseases (Johnson, 1984) . Cattle exposed to foot-and-mouth disease virus were shown to be persistently infected with temperature-sensitive mutants of the virus 12 months after the initial infection (Preble & Youngner, 1975) . Viruses which persist, particularly in the central nervous system (CNS), often have restricted gene expression, such as the measles virus in subacute sclerosing panencephalitis patients (Haase et al., 1985; Cattaneo et al., 1987) .
During persistent infections in vivo viruses acquire new mutations, i.e. Sindbis virus (Olmsted et al., 1984) , coronavirus (Wege et al., 1983) , Moloney murine leukaemia virus (Zachary et al., 1986 ) and vesicular stomatitis virus (VSV) (Hughes et al., 1979a, b) and often mutations that repress viral gene expression (Hughes & Johnson, 1981a; Johnson, 1984) .
Persisting viruses rely on a variety of mechanisms to maintain the host-parasite relationship. Several diseases appear to be elicited when persistent viruses evoke autoimmunity, i.e. systemic lupus erythematosus (Olsen et al., 1987) , multiple sclerosis (Whitaker & Kingsbury, 1984; Coyle & Procyk-Dougherty, 1984) and autoimmune connective tissue disorders (Rucheton et al., 1985) . Mice persistently infected with a temperature-sensitive mutant of VSV, tsG31 VSV, experienced a neuropathy that included hind-limb paralysis (Rabinowitz et al., 1976) . Cytopathologically, the CNS of mice persistently infected with tsG31 VSV displayed fusion of cells, chiefly dendrites and astrocytes, in the grey matter of the CNS (Rabinowitz et al., 1976; Dal Canto et al., 1976) . This fusion of cells resembled the status of spongiosus described in kuru patients and in other slow virus diseases (Gibbs et al., 1968) , and AIDS patients have been shown to have multinucleated cells in their CNS (Navia et al., 1986) . Cultured neuroblastoma cells fused when they were infected with tsG31 VSV and incubated at a non-permissive temperature for virus replication (Hughes et al., 1979a; Dille et al., 1981) .
Although mice persistently infected with tsG31 VSV suffered from neurological disorders, it was difficult to isolate infectious VSV from the animals after 5 days of infection. However, infectious VSV was retrieved from mice 90 days after infection, when they were treated with a hypothermia-inducing neuropeptide, bombesin (Hughes et al., 1985) . Neuropeptides also produced a more aggressive disease in mice persistently infected with temperature-sensitive mutants of VSV . Recovery of infectious VSV was formidable in persistently infected mice, as they had high titres of neutralizing antibody against VSV after 4 days of infection (Hughes et aL, 1985; Doll & Johnson, 1988a) . However, athymic (nude) mice did not have vigorous neutralizing antibody responses against tsG31-KS5 VSV, yet they all died from the persistent infection (Doll & Johnson, 1988a) . When nude mice were reconstituted with syngeneic T lymphocytes 24 h before inoculation with tsG31-KS5 VSV, 70~ of the animals survived and were persistently infected. The reconstituted nude mice normally had weak neutralizing antibody responses against the VSV and infectious VSV was readily isolated from their brains 30 days after infection (Doll & Johnson, 1988a) .
This report characterizes six temperature-sensitive VSV mutants that were isolated from the brains of five nude mice that had been reconstituted with syngeneic T lymphocytes and infected with tsG31-KS5 for 20 days (Doll & Johnson, 1988b) .
Methods
Animals. Outbred Swiss mice were purchased from the Charles River Breeding Laboratory. Three to 4 week old mice of both sexes were used and all mice were provided with food and water ad libitum.
Inoculation of mice with virus. Infection of mice has been described previously (Rabinowitz et al., 1976) . Briefly, 104 p.f.u, of VSV per 30 pl of Hanks' balanced salt solution (HBSS) (Hanks & Wallace, 1949) was injected into the frontal lobe of the animals' brains after the mice had been lightly anaesthetized with ether (Sigma).
Cell culture lines. BHK-21 cells were grown to confluence at 37 °C, in a humidified atmosphere of 5~ CO2 and 95~ air, in Dulbecco's modified eagle's medium (DMEM) (Flow Laboratories) containing 10~ calf serum (Hazelton Research Products) and supplemented as described previously (Rabinowitz et al., 1976) .
Viruses. tsG31 VSV (complementation group III) was generously provided by M. E. Reichmann (University of Illinois, Urbana, Ill., U.S.A.) and tsG31-KS5 VSV was a plaque-purified clone from tsG31 VSV that was selected for its inaggressive and persistent infection in the CNS of Swiss outbred mice (Doll & Johnson, 1988a) . Stock viruses were prepared with BHK-21 cells and were purified by density gradient centrifugation, as described previously (Rabinowitz et al., 1976) . Only B-type virions were used in these experiments.
Growth of viruses in BHK-21 cells. BHK-21 cells (1 x 106 to 2 x 106 cells per ml) were infected at an m.o.i, of 10. The virus was allowed to adsorb to the cells for 30 min at 25 °C and the cells were washed with 5.0 ml of HBSS and pelleted by centrifugation at 250 g for 3 min. The cells were washed twice more with HBSS, diluted to 1 x 105 to 2 x 105 cells per ml and incubated as suspensions in water baths. The water baths were maintained at their respective temperatures (31 °C or 38 °C), with a variation of _+0.2 °C throughout the incubation period. At various times post-infection, tubes were removed and frozen at -85°C until the number of infectious units (p.f.u.) could be determined with BHK-21 monolayers incubated at 31 °C.
Plaque assays. BHK-21 cells were cultured in six-well plates (35 x 10 ram; Costar) in 2.0 ml of DMEM. Confluent monolayers were infected with 0-1 ml of serial dilutions of the virus preparations. Virus was allowed to adsorb for 30 min at 25 °C and the wells were then overlaid with 2-0 ml of DMEM containing 0-37% agar (Difco). The infected monolayers were incubated at 31 °C in a 5% CO2 and 95% air atmosphere and, after incubation for 48 h, virus plaques were visualized by staining with crystal violet (Holland & McLaren, 1959) .
Viral RNA synthesis in cell cultures. BHK-21 cells (2 x 107) were infected with an m.o.i, of 10 p.f.u./cell in 500 p.1 of HBSS. Actinomycin D (Sigma) was added to a final concentration of 5 I.tg/ml. Virus was allowed to adsorb for 30 rain at 25 °C and then diluted to 6 ml with labelling medium consisting of HBSS supplemented with minimal essential medium vitamins (Hazelton Research Products), 100 units/ml of penicillin and streptomycin (K.C. Biological), 2.5 lag/ml of Fungizone (Hazelton Research Products), 2 mM-L-glutamine (Whittaker M.A. Bioproducts) and basal minimal essential amino acids (Hazelton Research Products). Infected cells were incubated at the appropriate temperature for 2 h, then radiolabelled with 5 pCi [3H]uridine/ml (50 Ci/mmol; ICN Radiochemicals) for 4 h. After incubation the cells were washed twice with HBSS and macromolecules were precipitated with 10~ TCA. The precipitate was washed onto 0.45 p.m filters, washed an additional five times with 10~ TCA and then counted in 3a70b scintillation fluid (Research Products International).
Isolation of template and enzyme fractions. Viral template and enzyme fractions of the viruses were isolated by the method described by Marks et al. (1985) , with the following modifications. B-type virions, purified from sucrose gradients, were disrupted with 10 mM-Tris-HC1 pH 7-4, 10% Nonidet-P40, 0.4 M-NaCI, 15% glycerol and 10 mM-dithiothreitol for 2 h at 4 °C. The ribonucleoprotein (RNP) was sedimented by centrifugation at 150000 g for 3 h. The RNP was collected and resuspended in 10 mM-Tris-HCl pH 8-0, 100 mM-NaC1 and 25~ glycerol (transcription buffer). An equal volume of 10 m~t-Tris-HC1, 4 M-NaCI, 2~ Nonidet-P40 and 2 mM-dithiothreitol was added and the solution was incubated at 4 °C overnight. The mixture was then centrifuged at 200000 g for 3 h. The supernatant (L and NS fraction) was dialysed against transcription buffer and the pellet (N RNA fraction) was resuspended in transcription buffer. The protein concentration of the N-RNA fraction was determined with the FolinCiocalteu phenol reagent (Sigma) and then diluted in transcription buffer to 1 pg of protein in 1 ktl.
Reconstitution of the template and enzyme fractions. The reconstitution assay was as described by De & Banerjee (1984) , with the following modifications. The reaction mixture (0.2 ml) contained 50 mM-Tris-HC1 pH 8.0, 5 mM-MgCl z, 4 mM-dithiothreitol, 100 mM-NaCI and 1 mM each of ATP, CTP and GTP. Either 20 gCi of [ct-32P]UTP (specific activity 800 Ci/mmol; NEN Research Products) was added to the reaction mixture, or 2 gCi of [3H]UTP (specific activity 35 Ci/mmol; ICN Radiochemicals) with 0.05 mM-UTP was added. Ten gg of the template and 10 lag of the enzyme fractions were added to each individual experiment; we found these amounts to be optimal for RNA synthesis in vitro. When [3H]UTP was used the reactions were stopped after 1 h by the addition of 1 ml of 0.067 M-sodium pyrophosphate. The RNA was precipitated with 20% TCA, the precipitates were collected on 0-45 lam filters, washed five times with 10% TCA and the radioactivity was determined in 3a70b scintillation fluid. When [ct-32p]UTP was used the reaction was stopped after 2 h by adding two and a half times the volume of cold ethanol and the RNA was precipitated and prepared for electrophoresis.
PAGE. The RNA products were analysed on a 20% polyacrylamide slab gel containing 8 M-urea. RNA bands were located by autoradiography with Curix RP1 film. The migration positions were marked in reference to xylene cyanol and bromophenol blue standards (De & Banerjee, 1985) .
Results
Nude mice that had been reconstituted with syngeneic T lymphocytes were infected with tsG31-KS5 VSV for 20 days, and infectious VSV was then isolated from the brains of the animals and cloned twice by plaque isolation (Doll & Johnson, 1988b) . All the brain-isolated clones were recovered from different mice, except BP3A VSV and BP3B VSV which were cloned from the same brain pool. Antisera made against wild-type wt VSV neutralized all the brain-isolated clones. Compared to tsG31-KS5 VSV, the brain-isolated clones yielded more aggressive infections when inoculated into Swiss outbred mice, with most of the animals dying by 20 days of infection (Table 1) . Numerous animals infected with brain-isolated clones, notable BP2A VSV and BP3A VSV, experienced CNS disorders, including hind-limb paralysis, 5 days after infection. However, BP5A VSV produced an infection more characteristic of tsG31-KS5 VSV, with only 10% of the animals exhibiting clinical manifestations of neurological disease.
Since most brain-derived clones spurred aggressive diseases in mice, the VSV growth kinetics were determined at 31 °C (a permissive temperature for tsG31-KS5 VSV replication) and at 38 °C (the normal body temperature of mice). All of the brain isolates produced more infectious VSV at 31 °C, as illustrated by BP2A VSV (Fig. 1) . Although the brain-isolated clones were temperature-sensitive for VSV replication all the isolates, except for BP5A VSV, produced more infectious VSV at 38 °C than tsG31-KS5 VSV (Table 1) . The more aggressive infections of the brain-isolated clones compared to tsG31-KS5 VSV may therefore be attributable to the amplified production of infectious VSV at the normal body temperature of mice. However, the small increase in the production of infectious VSV by the brain-isolated clones incubated at 38 °C, compared to tsG31-KS5 VSV, did not seem to be the only factor in the drastic differences in the clinical disease caused by these agents. At 31°C none of the CNS-derived VSV replicated as robustly as tsG31-KS5 VSV. BP5A VSV was more defective in virus replication than the other brain-isolated clones, yielding considerably less VSV than any other isolate, even at the permissive temperature, 31 °C. Although BP5A VSV did not produce detectable infectious VSV at 38 °C and did not produce an aggressive CNS disease, it was able to persist in the CNS for at least 20 days. Hughes & Johnson (1981b) have reported that VSV isolated from Swiss outbred mice, unlike tsG31 VSV, transcribed less RNA at 37 °C than at 31 °C. All the VSV recovered from the brains of persistently infected nude mice also had temperature-sensitive defects in RNA synthesis (Table 2 ). All the brain isolates, except for BP1B VSV, had normal yields of RNA at 31°C, including BP5A VSV, which had markedly reduced virus production at 31 °C (Table 1) . BPIB VSV had apparently lost a negative control mechanism for RNA synthesis, since at 31 °C it transcribed over twice the amount of RNA as either wt VSV or tsG31-KS5 VSV. However, at 38 °C all the CNS-derived VSV, including BP1B VSV, produced less than 50% of the RNA than either wt VSV or tsG31-KS VSV, but the decreased RNA synthesis did not completely arrest viral replication, since all the brainisolated VSV (except BP5A VSV) produced virus at 38 °C.
In vitro RNA synthesis transcription assays were used to define more precisely the nature of the temperature- sensitive defect in RNA production of the CNS-derived VSV. RNP complexes from brain isolates were purified by treating the virions with a 10~ Nonidet-P40 solution. The RNP complexes from the CNS-derived VSV were competent in RNA synthesis in in vitro assays performed at 31°C (Table 3 ). The wt VSV RNP complexes synthesized RNA equally well at 31 °C and at 38 °C. However, the brain-isolated VSV yielded more RNA at 31 °C than at 38 °C, reflecting the results of in vivo RNA synthesis (Table 2) . Although 10 ktg of RNP complex were used in each experiment, BP2A VSV synthesized approximately twice the amount of RNA, compared to the RNP complex from wt VSV at 31 °C (Table 3) .
Decreased gene expression has been proposed to be important in many persistent virus infections (Haase, 1986) , so we ascertained which protein(s) of the brainisolated VSV was limiting the synthesis of RNA at 38 °C. To determine which protein(s) of the RNP complexes was responsible for the altered transcription, the enzyme fractions (L protein and NS protein) were stripped from the template fractions (RNA and N protein) with 2 MNaC1. When each fraction was analysed by PAGE and silver staining, the enzyme fractions primarily contained L protein and NS protein with a small amount of N protein contaminant, and only N protein could be detected in the template fractions (data not shown). To establish the amount of each fraction required for saturation of the RNA synthesis assay, 10 ~tg/10 ktl of wt template was used with differing amounts of enzyme fraction. The most efficient transcription occurred when 10 ~tg/10 ~tl of the template fraction and 10 p_g of the enzyme fraction were used (data not shown); thus these concentrations were used in the ensuing experiments.
In vitro RNA synthesis assays were performed at 38 °C by reconstituting either the template or enzyme fraction from a brain VSV isolate, with the corresponding fraction isolated from wt VSV. All enzyme and template fractions were transcribed alone to ascertain that they were not significantly contaminated with the other fraction and all incorporated less than 10~o of the [3H]UMP measured in reactions with the homologous reconstitution of wt enzyme and template fractions. A control reaction with 10 ~tg of wt template plus 10 ~tg of wt enzyme fraction was carried out with each experiment and standardized to 100~o RNA synthesis. Homologous reconstitution with tsG31-KS5 VSV resulted in the same amount of RNA produced as the wt homologous reconstituted control (Table 4 ) and heterologous recombinations, with either wt fractions or the corresponding tsG31-KS5 VSV fractions, yielded comparable amounts of RNA.
With the exception of BP2A VSV, all of the homologous in vitro RNA synthesis assays, using CNS-derived VSV, had a marked reduction in the amount of RNA produced when compared to the wt VSV control (Table  4 ). The RNP complex of BP2A VSV synthesized an equal amount of RNA at 38 °C as did the RNP complex from wt VSV (Table 3) , thus this mutant may be functional in RNA synthesis in in vitro assays, but not in in vivo assays. With the exception of BP5A VSV, all of the enzyme fractions from brain isolates were functional in the in vitro RNA synthesis assays, because when mixed with template from wt VSV, RNA production was comparable to that of the homologous wt VSV control assay. However, the template fractions from all the CNSderived VSV provided markedly reduced transcription when they were incubated with the enzyme fraction of the wt VSV. BP5A VSV did not synthesize RNA when reconstituted with either fraction of wt VSV and probably had more than one protein that was functionally defective. Although BP4B VSV synthesized RNA when reconstituted with either fraction of wt VSV, greater than twice the amount of RNA was synthesized when wt template and BP4B VSV enzyme fraction were used instead of BP4B VSV template and wt VSV enzyme. When the wt template and BP4B VSV enzyme fraction were used 2-3 pg of [3H]UMP was incorporated into the RNA, compared to only 0-9 pg of [3H]UMP incorporated when BP4B VSV template was reconstituted with wt enzyme fractions. All the brain-isolated clones, except for BP2A, appeared to have a functionally mutated template fraction. Comparable results were obtained when tsG31-KS5 VSV replaced wt VSV fractions in heterologous reconstitution RNA synthesis assays (data not shown). Although the amount of RNA synthesized was rather low (Table 4 ) and the transcripts were relatively small (Fig. 2) , the measured activity probably represents a reasonable reflection of the polymerase activity when it synthesizes full-size mRNA.
Although RNA was synthesized when wt template was mixed with brain isolate enzyme fractions, these in vitro RNA synthesis assays did not discern whether transcription of the 47-base long leader sequence RNA and large Mr transcripts of VSV occurred (Banerjee, 1987) . To determine whether the leader sequence was transcribed under these experimental conditions, the in vitro RNA synthesis assays were carried out using [0t-32p]UTP as the radiolabelled precursor and the resulting RNA was sized on 20% polyacrylamide denaturing gels.
At 38 °C the enzyme fractions from brain isolates produced a significant amount of leader sequence size RNA, regardless of whether the template fraction was derived from tsG31-KS5 VSV, wt VSV, or the brain isolate as illustrated with BP2A VSV (Fig. 2) . Densitometric scanning of the leader sequence band indicated that the reconstitution of tsG31-KS5 template fraction with BP2A enzyme fractions made 31% of the leader sequence when compared with homologous template and enzyme fractions of tsG31-KS5. When BP2a template was used, in either homologous or heterologous reconstitution reactions, densitometric scanning showed only 33 % efficiency in transcription, compared to tsG31-KS5 reconstitution. Although BP2A VSV appeared to synthesize RNA in the previous experiment (Table 4) , homologous reconstitution of BP2A VSV template and enzyme fractions produced little, if any, leader sequence (Fig. 2) . However, when tsG31-KS5 VSV template was incubated with enzyme fractions of either tsG31-KS5 VSV or the brain isolates, leader sequence and mRNA was produced (Fig. 2) . However, only low Mr RNA
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Template
BP2A KS5 KS5 BP2A
Enzyme BP2A BP2A KS5 KS5 Fig. 2 . Heterologous reconstitution reactions with tsG31-KS5 VSV and BP2A VSV. Reconstitution reactions with the template and enzyme fractions isolated from tsG31-KS5 (KS5) and BP2A VSV (BP2A) were performed as detailed in the text. The RNA products were analysed by PAGE followed by autoradiography. The direction of electrophoresis was from top to bottom and the migration positions of leader RNA (L) and xylene cyanol (XC) are shown.
transcripts were observed, some of which migrated near the position of the leader RNA.
Discussion
Reduced virus gene expression is characteristic of many persistent viral infections (Haase, 1986) and it is conceivable that attenuated gene expression may be a selective advantage in the maintenance of an enduring host-parasite relationship. However, the mechanisms by which viruses abate gene expression have not yet been precisely documented. In this report we have shown that the template fractions (N protein and RNA) of all brainisolated VSV, that persisted in the CNS of nude mice for at least 20 days, had RNP complexes defective in in vitro RNA transcription. One brain isolate, BP5A VSV, apparently also had functional mutations in the enzyme fraction. The multiple mutations of BP5A VSV may explain its inhibited growth in cell culture, which yielded 100-to 1000-fold less infectious VSV than other temperature-sensitive VSV mutants, and also its persistent infection in Swiss outbred mice. Peptide maps of the proteins from VSV recovered from the brains of Swiss outbred mice infected with tsG31 VSV revealed only the N protein to be structurally different from the proteins of tsG31 VSV Hughes et al., 1985) . The RN P complex of VSV isolated from Swiss outbred mice was less stable than the RNP complexes isolated from either wt VSV or tsG31 VSV (Hughes & Johnson, 1980) . Although all of the RNP complex proteins, the N, L and NS proteins, are required for efficient transcription of the viral RNA, the precise role of each protein in transcription has not been elucidated. The L protein has been determined to be composed of at least one subunit of the polymerase (Emerson & Yu, 1975) . Initiation of transcription occurred in in vitro RNA transcription assays when only the L protein and not NS protein was added to the template fraction, but only oligonucleotides were made and no mRNA was transcribed (De & Banerjee, 1985) . Although NS protein does not appear to have any enzyme activity, it is required for elongation of mRNA during transcription (Banerjee, 1987) . The NS protein putatively binds to both the L protein and the N protein-RNA complex, thus aiding elongation (De & Banerjee, 1985) . The N protein of the VSV isolated from the CNS of nude mice may be mutated so that at 38 °C the NS protein cannot bind correctly, thus elongation of the mRNA cannot proceed. In some of the brain-isolated VSV mutants, it appeared that transcription occurred at 38 °C, but when the transcripts were sized on gels, the leader sequence and larger transcripts had not been produced (Fig. 2) . Transcription, therefore, may have been initiated, but only very small transcripts were produced, or nuclease activity and/or recovery may have caused difficulties.
Even though the CNS-derived VSV had the additional temperature-sensitive mutation associated with transcription, they produced more aggressive infections in mice when compared to tsG31-KS5 VSV and produced more infectious VSV in cell cultures incubated at 38 °C (Table 1) . Similar results were obtained earlier with CNS isolates from Swiss outbred mice (Hughes et al., 1979b) . How viruses with additional mutations produce more infectious VSV at 38 °C is not understood, although the ability of the virus to replicate at 38 °C may be essential to its ability to persist in the CNS.
It is interesting that VSV mutants that persist in the CNS have temperature-sensitive lesions largely associated with their N protein and not their L or NS proteins. The selection of N protein mutants in persistent VSV infections may help the virus to evade the host's immune defences. The nuclear protein has been shown to be important in immune protection against both hepatitis B virus (Milich & McLachlan, 1986) and influenza virus (Wraith et al., 1987) . Selection of VSV variants that are deficient in RNA synthesis also occurs in cell culture (Holland et al., 1979; Youngner et al., 1978) , thus evasion of one immune system was probably not the only selective force for this type of mutant. The ability of these VSV mutants to persist in the CNS may simply be because the N protein mutation allows decreased viral growth, through decreased gene expression and circumvents a rapid immune response from the host. Of course, we cannot rule out the possibility that there are also mutations in the enzyme fraction of the brain isolates that cannot be characterized with the methods used in this study.
